Diet Pills Market
Diet Pills Market Study by Prescription-Based Drugs, Over-the-Counter Drugs, and Herbal Supplements for Metabolism Raising, Fat Blocking, and Appetite Controlling From 2024 to 2034
Analysis of Diet Pills Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Diet Pills Market Outlook (2024 to 2034)
Revenue from the global diet pills market is estimated to reach US$ 1.8 billion in 2024. The market is analyzed to rise at a double-digit CAGR of 12.6% to reach US$ 5.89 billion by the end of 2034.
Innovation in research and development has resulted in the creation of novel diet pills with improved safety and efficacy profiles. To make products that appeal to health-conscious consumers, manufacturers are utilizing natural components, including conjugated linoleic acid, garcinia cambogia, and green tea extract in conjunction with technological advancements.
The weight loss supplement market is seeing an increase in innovation due to developments in technological integration, delivery methods, and constituent formulations. To increase efficacy, safety, and customer happiness in this dynamic industry, businesses consistently spend on research and development.
For example, in July 2022, the nutrition business Herbalife Nutrition introduced Fat Release, their most recent scientifically backed product. This product is for people who occasionally eat fatty foods with their meals; it is taken no later than two hours after eating. Fat Release contains Litramine, a proprietary cactus fiber substance derived from prickly pears that is well-known for its ability to reduce the absorption of fat.
One of the most significant markets is North America, which is followed by those in Europe, the United States, and some regions of Asia, including China and Japan. Nonetheless, new markets in Southeast Asia and Latin America are also expanding at a noteworthy rate. Prescription drugs for managing obesity include ligliglutide, phentermine, and orlistat.
Usually, these need to be under medical care. These pills are well-liked by customers looking for over-the-counter (OTC) remedies. These are consist of detoxifying tablets, hunger suppressants, fat burners, and metabolism boosters. As customer tastes for "clean" and natural ingredients rise, herbal and plant-based diet pills are becoming more popular.
| Report Attribute | Detail |
|---|---|
| Diet Pills Market Size (2024E) | US$ 1.8 Billion |
| Forecasted Market Value (2034F) | US$ 5.89 Billion |
| Global Market Growth Rate (2024 to 2034) | 12.6% CAGR |
| East Asia Market Share (2024E) | 17.6% |
| North America Growth Rate (2024 to 2034) | 15.1% CAGR |
| Demand for Over-the-Counter Drugs (2024E) | US$ 781.2 Million |
| Key Companies Profiled | Iovate Health Sciences Inc.; Zoller Laboratories; Cortislim; Nanjing Chang'ao Pharmaceutical Co.; Vivus, Inc.; Orexigen Therapeutics; GlaxoSmithKline Pharmaceuticals Ltd.; Zoller Laboratories. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the Factors in Favor of Rising Diet Pills Demand?
Increasing purchasing powers owing to rising gross domestic products of countries are driving demand for diet pills in the markets. The further aggregate amount of consumer awareness is the decisive force behind sales of diet pills. Health consciousness among people is the impetus behind the accelerating demand for diet pills.
Increased women and men workforce participation has given a stimulus to the projected growth in the diet pills market. As per the statistics, around 45 million Americans opt for a diet each year, resulting in spending USD 33 billion on weight loss products, including diet pills. This health-centricity is anticipating a rise in diet pills market revenue in the forecast duration.
The pills are being preferred as a comparatively cheaper option than other formulations. Diet pills are widely gaining acceptance by people of all age groups owing to more shelf life. The government initiatives for obesity control are fostering demand for diet pills.
Random weight gain, diabetes, and obesity issues are increasing, which is likely to propel diet pill sales. There is rising awareness among the public about the need for the prescription of dietary pills, and there is a shift in the trend of consumption of these supplements.
The role of nutritionists in the prescription of diet pills is determined these days by gym enthusiasts. Manufacturers of diet pills have given attention to these trends and focused more on the strategic marketing of their products. There is a progression in the medical research field, which is contributing to the rising demand for diet pills in the forecast period. Several companies have successfully launched different dietary pills in the market.
Restraints Affecting Demand for Diet Pills in the Market
The adverse effects, such as pulmonary hypertension associated with the overuse of dietary pills, are affecting sales of diet pills. In some incidences, these pills tend to provoke blood pressure, heart rate, and nervousness among consumers. Many prescription Diet pills are produced as per Schedules 3 and 4 of the controlled substance act. This is expected to prevent the reach of diet pills and make them reach only those who are in need.
Despite these laws in place, diet pills are being abused at an alarming frequency. The compliance and regulatory concerns associated with drug production are prime concerns of vendors in diet pills. Further, the cost of raw materials and retention of a strong supply chain network is challenging for diet pill manufacturers.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Segment wise analysis
Prescription-based Diet Pills to Thrive through 2032
There is positive growth in the prescription-based consumption of diet pills is expected to see the fastest growth rate owing to availability in the forms of chewable and sublingual pills. Vitamins and mineral diet pills dominate sales under the prescribed diet pills segment.
The mineral supplements in pill forms are expected to support weight management to foster metabolism and functioning. The majority of these tablets are prescribed for treating iron deficiencies across all age groups and enhancing health performance.
The herbal segment in diet pills is expected to see positive growth in the forecast duration owing to the demand for more vegan and plant-based diet products. The rising environmental concerns have a positive impact on the diet pills industry in terms of emerging opportunities for diet pills vendors. The herbal pills based he ingredients naturally derived from green tea extracts, caffeine, and green coffee beans leading to the present demand for diet pills in the market.
On the basis of application, diet pills are consumed as metabolism-raising pills, fat-blocking pills, and appetite-controlling pills. Diet pills are largely taken to increase the metabolism required for weight loss in people facing obesity issues. This segment is anticipated to mark a higher growth rate in the forecast period. Moreover, due to changing food quality and lifestyle issues, appetite-controlling pills are expected to drive sales in the forecast duration.
The offline distribution of diet pills dominated in 2020, accounting for the highest revenue of 70.4%. The hospital pharmacies and retail stores are prime distribution channels for diet pills offline sales. The health and beauty stores are also added segments of distribution which are positively affecting awareness and segment growth. Consumers tend to trust offline channels for the purchase of medicines and diet supplements owing to prevention against counterfeit products.
Moreover, online channels are expected to record the fastest CAGR value in the forecast duration. Online retailers offering attractive discounts and monthly prescriptions tend to strive for customer preferences. The online channels widely opt for their ability to distribute at various locations outlining offline stores. The rising self-driven customers are likely to be drivers of this segment’s growth in the forecast duration.
Regional Insights
Novel Opportunities to Arise in the Diet Pills Market in Asia Pacific
The sales of diet pills are centered in the Asia Pacific region due to the high prevalence of obesity issues and rising health consciousness. The region also experiences rising incomes, which raises pocket expenditure by people. The adult populace in the region relies on diet pills for weight management to gain proper physics.
There are novel opportunities in terms of product development and distribution channels in this region, as marked by growing demand. The rising diseases and lifestyle issues are drivers of demand for diet pills in the forecast duration in Asia Pacific markets.
The North American region is expected to mark the second-highest growth rate, as there is a disquieting rise in patients with overweight and unhealthy diet patterns. The people of this region are well aware of the importance of fitness training resulting in rising gym memberships. Alongside there are big industry players present in the market anticipated to drive growth in sales of diet pills.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Strategies by Key Players in the Diet Pills Market
The diet pills industry is likely to notice a rise in competition among dominant firms. However, the manufacturing of diet pills is a capital incentive process imposing challenges for start-ups in the sector. The key players in the market opt for product research, strategic collaborations, and extensive promotion of products. Companies are paying equal importance to sustainable production by focusing on making it a priority throughout the production cycle.
- In September 2023, GSK launched a sustainable procurement program for suppliers that ensures commitment to enhance emission and energy management aiming to reduce the carbon impact of the firm.
- In August 2022, a Leading US manufacturer of diet pills Currax Pharmaceuticals LLC launched the “One size does not fit all” campaign to address emotional challenges for individuals seeking weight loss.
Segmentation of Diet Pills Market Research
-
By Product Type :
- Prescription Based Drugs
- Over the Counter Drugs
- Herbal Supplements
-
By Application :
- Metabolism Raising Pills
- Fat Blocking Pills
- Appetite Controlling Pills
-
By Distribution channel :
- Hospital Pharmacy
- Retail Pharmacy
- Drug Stores
-
By Region :
- North America
- Easter Europe
- Western Europe
- East Asia
- Latin America
- South Asia & Pacific
- Eastern Europe
- Middle East & Africa
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Product Type 6.2. Application 6.3. Distribution Channel 7. Global Market Analysis and Forecast, By Product Type 7.1. Prescription Based Drugs 7.2. Over the Counter Drugs 7.3. Herbal Supplements 8. Global Market Analysis and Forecast, By Application 8.1. Metabolism Raising Pills 8.2. Fat Blocking Pills 8.3. Appetite Controlling Pills 8.4. Others 9. Global Market Analysis and Forecast, By Distribution Channel 9.1. Hospital Pharmacy 9.2. Retail Pharmacy 9.3. Drug Stores 10. Global Market Analysis and Forecast, By Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. East Asia 10.6. South Asia & Pacific 10.7. MEA 11. North America Sales Analysis and Forecast, by Key Segments and Countries 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries 17. MEA Sales Analysis and Forecast, by Key Segments and Countries 18. Sales Forecast by Product Type, Application, and Distribution Channel for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. GlaxoSmithKline Pharmaceuticals Ltd. 20.2. Iovate Health Sciences Inc. 20.3. Zoller Laboratories 20.4. Cortislim 20.5. Nanjing Chang'ao Pharmaceutical Co. 20.6. Vivus, Inc. 20.7. Orexigen Therapeutics
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Bn Forecast by Region
Table 2: Global Market US$ Bn Forecast by Product Type
Table 3: Global Market US$ Bn Forecast by Application
Table 4: Global Market US$ Bn Forecast by Distribution Channel
Table 5: North America Market US$ Bn Forecast by Country
Table 6: North America Market US$ Bn Forecast by Product Type
Table 7: North America Market US$ Bn Forecast by Application
Table 8: North America Market US$ Bn Forecast by Distribution Channel
Table 9: Latin America Market US$ Bn Forecast by Country
Table 10: Latin America Market US$ Bn Forecast by Product Type
Table 11: Latin America Market US$ Bn Forecast by Application
Table 12: Latin America Market US$ Bn Forecast by Distribution Channel
Table 13: Western Europe Market US$ Bn Forecast by Country
Table 14: Western Europe Market US$ Bn Forecast by Product Type
Table 15: Western Europe Market US$ Bn Forecast by Application
Table 16: Western Europe Market US$ Bn Forecast by Distribution Channel
Table 17: Eastern Europe Market US$ Bn Forecast by Country
Table 18: Eastern Europe Market US$ Bn Forecast by Product Type
Table 19: Eastern Europe Market US$ Bn Forecast by Application
Table 20: Eastern Europe Market US$ Bn Forecast by Distribution Channel
Table 21: East Asia Market US$ Bn Forecast by Country
Table 22: East Asia Market US$ Bn Forecast by Product Type
Table 23: East Asia Market US$ Bn Forecast by Application
Table 24: East Asia Market US$ Bn Forecast by Distribution Channel
Table 25: South Asia & Pacific Market US$ Bn Forecast by Country
Table 26: South Asia & Pacific Market US$ Bn Forecast by Product Type
Table 27: South Asia & Pacific Market US$ Bn Forecast by Application
Table 28: South Asia & Pacific Market US$ Bn Forecast by Distribution Channel
Table 29: MEA Market US$ Bn Forecast by Country
Table 30: MEA Market US$ Bn Forecast by Product Type
Table 31: MEA Market US$ Bn Forecast by Application
Table 32: MEA Market US$ Bn Forecast by Distribution Channel
Table 33: Region Market US$ Bn Forecast by Country
Table 34: Region Market US$ Bn Forecast by Product Type
Table 35: Region Market US$ Bn Forecast by Application
Table 36: Region Market US$ Bn Forecast by Distribution Channel
Table 37: North America Market US$ Bn Forecast by Country
Table 38: North America Market US$ Bn Forecast by Product Type
Table 39: North America Market US$ Bn Forecast by Application
Table 40: North America Market US$ Bn Forecast by Distribution Channel
Table 41: Latin America Market US$ Bn Forecast by Country
Table 42: Latin America Market US$ Bn Forecast by Product Type
Table 43: Latin America Market US$ Bn Forecast by Application
Table 44: Latin America Market US$ Bn Forecast by Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Application
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Distribution Channel
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Application
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Distribution Channel
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Application
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Distribution Channel
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Application
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Distribution Channel
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Application
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Distribution Channel
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Application
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Distribution Channel
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Application
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Distribution Channel
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Application
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Distribution Channel
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 33: Region Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 34: Region Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Application
Figure 35: Region Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Distribution Channel
Figure 36: Region Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 37: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 38: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Application
Figure 39: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Distribution Channel
Figure 40: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 41: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Product Type
Figure 42: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Application
Figure 43: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Distribution Channel
Figure 44: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current growth outlook for the diet pills market?
At present, the diet pills market valuation is US$ 1.8 billion in 2024.
What is the future growth outlook for the diet pills market?
The healthcare diet pills market is evaluated to reach a valuation of USD 5.89 billion by the end of 2034.
What is the growth rate for the diet pills market across the world?
This market is projected to grow at a CAGR of 12.6% in the forecast period from 2024 to 2034.
Which segment is evaluated to grow in terms of application in the diet pills market?
The prescribed diet pills segment is analyzed to lead in terms of market share in the forecast duration.
Diet Pills Market